Goldman Sachs’s DexCom DXCM Stock Holding History

Goldman Sachs’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.23M	Sell	147,000 -648,000	-82%	-$45.1M	﹤0.01%	3134
2025 Q4	$52.8M	Buy	795,000 +533,000	+203%	+$34.5M	0.01%	1471
2025 Q3	$17.6M	Buy	262,000 +77,000	+42%	+$6.09M	﹤0.01%	2385
2025 Q2	$16.1M	Buy	185,000 +100,000	+118%	+$7.84M	﹤0.01%	2318
2025 Q1	$5.8M	Buy	85,000 +47,500	+127%	+$3.88M	﹤0.01%	3202
2024 Q4	$2.92M	Hold	37,500	–	–	﹤0.01%	3975
2024 Q3	$2.51M	Hold	37,500	–	–	﹤0.01%	3950
2024 Q2	$4.25M	Buy	37,500 +13,300	+55%	+$1.68M	﹤0.01%	3312
2024 Q1	$3.36M	Sell	24,200 -6,000	-20%	-$754K	﹤0.01%	3446
2023 Q4	$3.75M	Buy	+30,200	New	+$3.09M	﹤0.01%	3401
2022 Q4	–	Sell	-9,400	Closed	-$757K	–	6045
2022 Q3	$757K	Buy	+9,400	New	+$796K	﹤0.01%	4700
2021 Q2	–	Sell	-40,000	Closed	-$3.59M	–	6267
2021 Q1	$3.59M	Buy	40,000 +36,000	+900%	+$3.38M	﹤0.01%	3446
2020 Q4	$370K	Hold	4,000	–	–	﹤0.01%	4782
2020 Q3	$412K	Hold	4,000	–	–	﹤0.01%	4585
2020 Q2	$405K	Buy	+4,000	New	+$358K	﹤0.01%	4477
2016 Q2	–	Sell	-120,000	Closed	-$2.04M	–	7058
2016 Q1	$2.04M	Buy	+120,000	New	+$2M	﹤0.01%	3449
2015 Q1	–	Sell	-175,600	Closed	-$2.42M	–	7118
2014 Q4	$2.42M	Hold	175,600	–	–	﹤0.01%	3654
2014 Q3	$1.76M	Buy	+175,600	New	+$1.79M	﹤0.01%	4065
2014 Q1	–	Sell	-113,200	Closed	-$1M	–	6793
2013 Q4	$1M	Buy	+113,200	New	+$896K	﹤0.01%	4743

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs's DXCM Position: Q1 2026 in Review

Goldman Sachs increased its DexCom (DXCM) stake by 25% in Q1 2026, buying an estimated $42.2M and bringing the position to 3,043,635 shares worth $191M. The position accounts for 0.02% of the portfolio, ranked #695.

Goldman Sachs first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $495M in Q2 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Goldman Sachs held 3,043,635 shares of DexCom worth $191M as of Q1 2026.
Goldman Sachs bought 605,788 DexCom shares in Q1 2026, an estimated $42.2M.
DexCom made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #695 holding.
Goldman Sachs first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
Goldman Sachs's DexCom position peaked at $495M in Q2 2020.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.